How do you assess whether an early-stage Hodgkin's patient is unfavorable?

The unfavorable risk factors for stage I-II Classic Hodgkin's Lymphoma differ depending on the cooperative group (GHSG, EORTC, NCCN), which criteria do you use?

1 Answer

Mednet MemberInvited Expert

Radiation Oncology · Duke University Medical Center

Answered on

I personally utilize the GHSG criteria for most patients. To review, a patient has "favorable" disease if they meet all of the following criteria:

1. 1-2 involved sites

2. No bulky disease

3. No extranodal disease (which is rare in early-stage HL)

4. Favorable ESR/B-symptoms profile (ESR < 30 with B...

Join for free or sign in to see the full answer